Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials.
Saved in:
| Title: | Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials. |
|---|---|
| Authors: | Zhang, Shu-Ling1 (AUTHOR), Yi, Xiao-Fang1 (AUTHOR), Huang, Le-Tian1 (AUTHOR), Sun, Li1 (AUTHOR), Ma, Jie-Tao1 (AUTHOR), Han, Cheng-Bo1 (AUTHOR) han_cb@126.com |
| Source: | BMC Cancer. 8/1/2023, Vol. 23 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-023-11194-6 |
